Search Results - "Olyaei, Ali J."

Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry by Horn, David L., Neofytos, Dionissios, Anaissie, Elias J., Fishman, Jay A., Steinbach, William J., Olyaei, Ali J., Marr, Kieren A., Pfaller, Michael A., Chang, Chi-Hsing, Webster, Karen M.

“…Background. Candidemia remains a major cause of morbidity and mortality in the health care setting, and the epidemiology of Candida infection is changing…”
Get full text

A quantitative approach to drug dosing in chronic kidney disease by Olyaei, Ali J, Steffl, Jessica L

“…Chronic kidney disease (CKD) is increasing at an alarming rate. Medication prescribing in this growing population is especially difficult. Many pharmacological…”
Get more information

The role of the pharmacist in the management of kidney transplant recipients by Wiegel, Joshua, Olyaei, Ali

“…Pharmacists may play a key role on the multidisciplinary transplant team. This article describes the development and current status of pharmacists in the…”
Get full text

Drug Dosing in Elderly Patients with Chronic Kidney Disease by Lassiter, Jessica, PharmD, BCPS, Bennett, William M., MD, Olyaei, Ali J., PharmD

“…As the elderly population in the United States increases, health care professionals need to be aware of potential age-related changes that affect medication…”
Get full text

Drug Dosing in the Elderly Patients with Chronic Kidney Disease by Olyaei, Ali J., PharmD, Bennett, William M., MD

“…Chronic kidney disease is a common disorder that affects many patients with a prevalence approaching 19 million people in the United States. Kidney failure and…”
Get full text

Presentation of the PATH Alliance® registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections by Horn, David L, Fishman, Jay A, Steinbach, William J, Anaissie, Elias J, Marr, Kieren A, Olyaei, Ali J, Pfaller, Michael A, Weiss, Mark A, Webster, Karen M, Neofytos, Dionissios

“…Abstract Randomized clinical trials for patients with invasive fungal infections (IFIs) are often limited or precluded, necessitating alternate sources of…”
Get full text

Sulfonamide desensitization in solid organ transplant recipients: A protocol‐driven approach during the index transplant hospitalization by Pryor, Joseph B., Olyaei, Ali J., Kirsch, Denise, Strasfeld, Lynne

“…Trimethoprim‐sulfamethoxazole (TMP‐SMX) is the first‐line agent for Pneumocystis jiroveci pneumonia (PJP) prophylaxis for solid organ transplant (SOT)…”
Get full text

The Old and New Methods of Assessing Kidney Function by Steffl, Jessica L., Bennett, William, Olyaei, Ali J.

“…Chronic kidney disease is a worldwide problem. Accurate assessment of kidney function is important for defining stages of kidney disease and assisting with…”
Get full text

Association of fungal infection and increased mortality in liver transplant recipients by Rabkin, John M, Oroloff, Susan L, Corless, Christopher L, Benner, Kent G, Flora, Ken D, Rosen, Hugo R, Olyaei, Ali J

“…Background: Invasive fungal infection is associated with increased morbidity and mortality following orthotopic liver transplantation (OLTx). Understanding the…”
Get full text

New onset diabetes after kidney transplantation in Asian Americans – Is there an increased risk? by Lockridge, Joseph B., Pryor, Joseph B., Stack, Megan N., Rehman, Shehzad S., Norman, Douglas J., DeMattos, Angelo M., Olyaei, Ali J.

“…New-onset diabetes after transplantation (NODAT) is increasing in frequency and creates many challenges directly impacting the patient and graft survival. Most…”
Get full text

Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies by Olyaei, A J, de Mattos, A M, Bennett, W M

“…Cyclosporine and tacrolimus reduce allograft rejection, improve allograft half-life and patient survival. Ironically, the nephrotoxicity of these agents may…”
Get full text

Lipid-lowering agents for the treatment of hyperlipidemia in patients with chronic kidney disease and end-stage renal disease on dialysis: a review by Pryor, Joseph B., Weber, Bo R., Weber, Jacob V., Lockridge, Joseph B., Olyaei, Ali J.

“…Cardiovascular disease (CVD) continues to be the leading cause of death in Western civilizations, and hyperlipidemia is a well-established independent risk…”
Get full text

Nephrotoxicity of immunosuppressive drugs: Long-term consequences and challenges for the future by de Mattos, Angelo M., Olyaei, Ali J., Bennett, William M.

“…The calcineurin inhibitors cyclosporin A (CsA) and tacrolimus (FK506) are associated with dose- and efficacy-limiting adverse events, including nephrotoxicity,…”
Get full text

Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation by De Mattos, Angelo M., Olyaei, Ali J., Prather, Jonathan C., Golconda, Muralikrishna S., Barry, John M., Norman, Douglas J.

“…Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation. Posttransplant diabetes mellitus is an…”
Get full text

Immunosuppression impact on long-term cardiovascular complications after liver transplantation by Rabkin, John M., Corless, Christopher L., Rosen, Hugo R., Olyaei, Ali J.

“…Background: With current early transplant patient and allograft survivals nearly optimized, long-term medical complications have become a significant focus for…”
Get full text

Late mortality after orthotopic liver transplantation by Rabkin, John M, de La Melena, Violetta, Orloff, Susan L, Corless, Christopher L, Rosen, Hugo R, Olyaei, Ali J

“…Background: Mortality within the first year after orthotopic liver transplantation (OLTx) is usually due to infection or allograft failure. Late complications…”
Get full text

Hepatitis C infection increases the risk of new-onset diabetes after transplantation in liver allograft recipients by Soule, Jordana L., Olyaei, Ali J., Boslaugh, Tobin A., Busch, Ann M.H., Schwartz, Jonathan M., Morehouse, Samuel H., Ham, John M., Orloff, Susan L.

“…Recent evidence suggests that new-onset diabetes after transplant (NODAT) adversely affects orthotopic liver transplant (OLTX) patient and graft survival. The…”
Get full text

Cardiovascular complications of immunosuppressive agents in renal transplant recipients by Olyaei, Ali J, Demattos, Angelo M, Bennett, William M

“…Fatal and nonfatal cardiovascular events are the most important cause of graft loss in patients with a functioning graft following transplantation. The…”
Get more information

Distant processing of pancreas islets for autotransplantation following total pancreatectomy by Rabkin, John M, Olyaei, Ali J, Orloff, Susan L, Geisler, Sarah M, Wahoff, David C, Hering, Bernard J, Sutherland, David E.R

“…background: Small duct chronic pancreatitis is associated with intractable pain and failure to thrive, usually unresponsive to conventional management…”
Get full text

Renal toxicity of protease inhibitors by Olyaei, Ali J, deMattos, Angelo M, Bennett, William M

“…Introduction of several classes of antiviral agents for the treatment of immunodeficiency virus has led to increased survival and improved quality of life for…”
Get full text